0
Article |

Immune Response in Patients Who Received Blood Containing Serum Hepatitis Antigen FREE

Alfred M. Prince, MD; Betsy Brotman; Charles E. Cherubin, MD
[+] Author Affiliations

Reprint requests to New York Blood Center, 310 E 67th St, New York 10021 (Dr. Prince).


Am J Dis Child. 1972;123(4):415-418. doi:10.1001/archpedi.1972.02110100147057.
Text Size: A A A
Published online

Conventional methods for detection of SH (Australia antigen, HAA) antigen and corresponding antibody, such as agar gel diffusion (AGD), immunoelectroosmophoresis (IEOP), and complement fixation (CF), have failed to incriminate hepatitis virus type B in a major portion of cases of posttransfusion hepatitis.1,2 It has not been possible to determine whether this reflects only the inadequate sensitivity of these assay methods or whether these findings reflect the role of other viruses, lacking an association of the SH antigen, in the etiology of posttransfusion hepatitis. It has been recognized that introduction of more sensitive methods, such as radioimmune assay3 or hemagglutination inhibition (HAI)4 may provide an answer. We report an investigation of patterns of immune response as shown by passive HA technique in 35 patients inadvertently transfused with blood containing SH antigen. Serological evidence of infection with hepatitis virus type B has been obtained in 34 of the 35

REFERENCES

Purcell RH, Holland PV, Walsh JH, et al:  A complement fixation technique for measuring Australia antigen and antibody . J Infect Dis 120:383-386, 1969;.
Prince AM, Szmuness W, Millian SJ, et al:  A serological study of cytomegalovirus infections associated with blood transfusions . New Eng J Med 284:1125-1131, 1971;.
Walsh JH, Yalow RS, Berson SA:  Detection of Australia antigen and antibody by means of radioimmuno assay techniques . J Infect Dis 121:550-554, 1970;.
Vyas GN, Shulman NR:  Hemagglutination assay for antigen and antibody associated with viral hepatitis . Science 170:332-333, 1970;.
Prince AM:  An antigen detected in the blood during the incubation period of serum hepatitis . Proc Nat Acad Sci 60:814-821, 1968;.
Prince AM, Burke K:  Serum hepatitis antigen (SH): Rapid detection by high voltage immunoelectroosmophoresis . Science 169:593-595, 1970;.
Prince AM, Szmuness W, Wood KR, et al:  Antibody against serum hepatitis antigen: Prevalence and potential use as an immune serum globulin in prevention of serum hepatitis infections . New Eng J Med 285:933-938, 1971;.
Wroblewski F, LaDue JS:  Serum glutamic pyruvic transaminase in cardiac and hepatic disease . Proc Soc Exp Biol Med 91:571-576, 1956;.
Gocke DJ, Kavey NB:  Hepatitis antigen: Correlation with disease and infectivity of blood donors . Lancet 2:1055-1057, 1969;.
Lander JJ, Giles JP, Purcell RH, et al:  Viral hepatitis, type B (MS-2 strain): Detection of antibody after primary infection . New Eng J Med 285:303-307, 1971;.
Holland RV, Walsh JH, Morrow AG, et al:  Failure of Australia antibody to prevent post-transfusion hepatitis . Lancet 2:553-555, 1969;.
Greenberg HB, Gocke DJ:  An analysis of antibody response to Australia antigen in man . J Infect Dis 123:356-364, 1971;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Purcell RH, Holland PV, Walsh JH, et al:  A complement fixation technique for measuring Australia antigen and antibody . J Infect Dis 120:383-386, 1969;.
Prince AM, Szmuness W, Millian SJ, et al:  A serological study of cytomegalovirus infections associated with blood transfusions . New Eng J Med 284:1125-1131, 1971;.
Walsh JH, Yalow RS, Berson SA:  Detection of Australia antigen and antibody by means of radioimmuno assay techniques . J Infect Dis 121:550-554, 1970;.
Vyas GN, Shulman NR:  Hemagglutination assay for antigen and antibody associated with viral hepatitis . Science 170:332-333, 1970;.
Prince AM:  An antigen detected in the blood during the incubation period of serum hepatitis . Proc Nat Acad Sci 60:814-821, 1968;.
Prince AM, Burke K:  Serum hepatitis antigen (SH): Rapid detection by high voltage immunoelectroosmophoresis . Science 169:593-595, 1970;.
Prince AM, Szmuness W, Wood KR, et al:  Antibody against serum hepatitis antigen: Prevalence and potential use as an immune serum globulin in prevention of serum hepatitis infections . New Eng J Med 285:933-938, 1971;.
Wroblewski F, LaDue JS:  Serum glutamic pyruvic transaminase in cardiac and hepatic disease . Proc Soc Exp Biol Med 91:571-576, 1956;.
Gocke DJ, Kavey NB:  Hepatitis antigen: Correlation with disease and infectivity of blood donors . Lancet 2:1055-1057, 1969;.
Lander JJ, Giles JP, Purcell RH, et al:  Viral hepatitis, type B (MS-2 strain): Detection of antibody after primary infection . New Eng J Med 285:303-307, 1971;.
Holland RV, Walsh JH, Morrow AG, et al:  Failure of Australia antibody to prevent post-transfusion hepatitis . Lancet 2:553-555, 1969;.
Greenberg HB, Gocke DJ:  An analysis of antibody response to Australia antigen in man . J Infect Dis 123:356-364, 1971;.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.